These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15839805)

  • 1. Rolipram attenuates MK-801-induced deficits in latent inhibition.
    Davis JA; Gould TJ
    Behav Neurosci; 2005 Apr; 119(2):595-602. PubMed ID: 15839805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent inhibition of cued fear conditioning: an NMDA receptor-dependent process that can be established in the presence of anisomycin.
    Lewis MC; Gould TJ
    Eur J Neurosci; 2004 Aug; 20(3):818-26. PubMed ID: 15255992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction mechanisms within the entorhinal cortex that support latent inhibition of cued fear conditioning.
    Lewis MC; Gould TJ
    Neurobiol Learn Mem; 2007 Oct; 88(3):359-68. PubMed ID: 17560814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism.
    Zhang HT; Crissman AM; Dorairaj NR; Chandler LJ; O'Donnell JM
    Neuropsychopharmacology; 2000 Aug; 23(2):198-204. PubMed ID: 10882846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methyl-D-aspartate receptors play important roles in acquisition and expression of the eyeblink conditioned response in glutamate receptor subunit delta2 mutant mice.
    Kato Y; Takatsuki K; Kawahara S; Fukunaga S; Mori H; Mishina M; Kirino Y
    Neuroscience; 2005; 135(4):1017-23. PubMed ID: 16165299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nobiletin, a citrus flavonoid, reverses learning impairment associated with N-methyl-D-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling.
    Nakajima A; Yamakuni T; Matsuzaki K; Nakata N; Onozuka H; Yokosuka A; Sashida Y; Mimaki Y; Ohizumi Y
    J Pharmacol Exp Ther; 2007 May; 321(2):784-90. PubMed ID: 17289833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditioned stimulus familiarity determines effects of MK-801 on fear extinction.
    Chan WY; McNally GP
    Behav Neurosci; 2009 Apr; 123(2):303-14. PubMed ID: 19331454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia.
    Grauer SM; Pulito VL; Navarra RL; Kelly MP; Kelley C; Graf R; Langen B; Logue S; Brennan J; Jiang L; Charych E; Egerland U; Liu F; Marquis KL; Malamas M; Hage T; Comery TA; Brandon NJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):574-90. PubMed ID: 19661377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications.
    Maxwell CR; Kanes SJ; Abel T; Siegel SJ
    Neuroscience; 2004; 129(1):101-7. PubMed ID: 15489033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4'-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA/ERK/CREB signaling, rescues learning impairment associated with NMDA receptor antagonism via stimulation of the ERK cascade.
    Al Rahim M; Nakajima A; Saigusa D; Tetsu N; Maruyama Y; Shibuya M; Yamakoshi H; Tomioka Y; Iwabuchi Y; Ohizumi Y; Yamakuni T
    Biochemistry; 2009 Aug; 48(32):7713-21. PubMed ID: 19601643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type IV phosphodiesterase inhibitor rolipram disturbs expression and extinction of conditioned fear in mice.
    Mueller EM; Hofmann SG; Cherry JA
    Neuropharmacology; 2010; 59(1-2):1-8. PubMed ID: 20362594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
    Schmidt AP; Tort AB; Silveira PP; Böhmer AE; Hansel G; Knorr L; Schallenberger C; Dalmaz C; Elisabetsky E; Crestana RH; Lara DR; Souza DO
    Pharmacol Biochem Behav; 2009 Feb; 91(4):549-53. PubMed ID: 18854198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA antagonist MK-801 does not interfere with the use of spatial representation in a familiar environment.
    Uekita T; Okaichi H
    Behav Neurosci; 2005 Apr; 119(2):548-56. PubMed ID: 15839801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
    Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T
    Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent inhibition in rats neonatally treated chronically with MK-801: differential effects on conditioned taste aversion and conditioned emotional response.
    Niikura R; Nozawa T; Yamada K; Kato K; Ichitani Y
    Behav Brain Res; 2015 Apr; 283():102-7. PubMed ID: 25629943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rolipram, a selective phosphodiesterase type-IV inhibitor, prevents induction of heat shock protein HSP-70 and hsp-70 mRNA in rat retrosplenial cortex by the NMDA receptor antagonist dizocilpine.
    Hashimoto K; Tomitaka S; Bi Y; Narita N; Minabe Y; Iyo M
    Eur J Neurosci; 1997 Sep; 9(9):1891-901. PubMed ID: 9383212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the NMDA receptor antagonist MK-801 on the acquisition and extinction of learned fear in the developing rat.
    Langton JM; Kim JH; Nicholas J; Richardson R
    Learn Mem; 2007 Oct; 14(10):665-8. PubMed ID: 17909101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
    Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR
    Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801.
    Pitsikas N; Zisopoulou S; Sakellaridis N
    J Neurosci Res; 2006 Aug; 84(2):299-305. PubMed ID: 16710846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo.
    Gilbert ME; Lasley SM
    Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.